Visiogen
Ophthalmic medical device company developing vision alternatives for patients with cataracts, with and without presbyopia.
Launch date
Employees
Market cap
-
Enterprise valuation
$400m (Public information from Sep 2009)
Irvine California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$5.0m | Series B | ||
$16.5m | Late VC | ||
$24.0m | Late VC | ||
$40.0m | Series D | ||
$400m Valuation: $400m | Acquisition | ||
| Total Funding | $85.5m | ||